Absci

ABSI · NASDAQ

$9.07+$0.53 (+6.21%)TodayMarket closed ·
Prev close $8.54

Latest news

  • Press releaseGlobe Newswire

    AI-Designed Biologics Are Moving From the Screen to the Bench, and Developers Are Hiring for the Next Test

  • News

    10 Health Care Stocks With Whale Alerts In Today’s Session

  • NewsAvi Kapoor

    Humana, Evolution Metals & Technologies, Fastly And Other Big Stocks Moving Higher On Friday

  • Press releaseGlobe Newswire

    Absci Announces Preliminary Details for Phase 2 STORYLINE™ Trial of AI-Designed Antibody ABS-201™ for Endometriosis

  • NewsVandana Singh

    Eli Lilly Utilizes Weight-Loss Drug Profits To Fund Women's Health Initiatives: Report

  • Press releasePRNewswire

    AI in Drug Discovery Market Projected to Reach $8.52 Billion By 2030

  • Press releaseGlobe Newswire

    Most AI Drug Discovery Reads the Genetic Code. The Next Wave Is Learning to Read What the Code Actually Does.

  • NewsAvi Kapoor

    National CineMedia Posts Downbeat Q2 Results, Joins Borr Drilling, AbCellera Biologics And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session

  • News

    12 Health Care Stocks Moving In Tuesday's After-Market Session

  • Press releaseGlobe Newswire

    Absci Reports Business Updates and Second Quarter 2026 Financial and Operating Results

  • Press releasePRNewswire

    A Small AI Company Just Took the Stage at One of the Biggest Events in Computing, and It Points to Where Drug Discovery Is Headed

  • Press releasePRNewswire

    As AI Rewrites Drug Discovery, This Bio-Native AI Company Just Joined the Russell 3000E, and Reports Earnings July 22

  • Press releasePRNewswire

    As AI Models Become Commodities, a Bio-Native AI Company Just Moved to Patent the Data Layer Beneath the Models

  • Press releasePRNewswire

    The Quantum Sector Hits an Inflection Point: Federal Money, Real Milestones, and a Security Race Running in Parallel

  • NewsSurbhi Jain

    Anthropic Is Going All In on Drug Discovery Just as Pharma Stops Talking About AI

  • News

    12 Health Care Stocks Moving In Wednesday's Intraday Session

  • NewsVandana Singh

    Absci Raises $100 Million In Equity To Fund AI-Designed Hair Loss And Endometriosis Program

  • News

    12 Health Care Stocks Moving In Wednesday's Pre-Market Session

  • Press releaseGlobe Newswire

    Absci Announces Pricing of $100 Million Underwritten Offering with Leading Strategic and Financial Investors

  • Press releaseGlobe Newswire

    Absci Announces Positive Interim Phase 1 Data from the HEADLINE™ Trial of ABS-201, a Novel Antibody Targeting the Prolactin Receptor (PRLR)

  • Press releasePRNewswire

    The Quiet Bottleneck in AI Drug Discovery Isn't the Model -- It's the Biology Underneath It

  • Press releaseBusiness Wire

    MindWalk (NASDAQ: HYFT) CEO Dr. Jennifer Bath to Join Absci (NASDAQ: ABSI) and a Leading AI Compute Provider on Jones AI Day Panel on the Future of AI Drug Discovery

  • News

    12 Health Care Stocks Moving In Friday's Pre-Market Session

  • NewsAvi Kapoor

    Absci, DigitalOcean And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

  • NewsAvi Kapoor

    Why Blaize Holdings Shares Are Trading Higher By Around 41%; Here Are 20 Stocks Moving Premarket

  • News

    12 Health Care Stocks Moving In Tuesday's After-Market Session

  • Press releasePRNewswire

    AI Creation Engines Transform Biotech as Wellness Tech Captures Growth Wave

  • News

    12 Health Care Stocks Moving In Thursday's Intraday Session

  • News

    12 Health Care Stocks Moving In Thursday's Pre-Market Session

  • NewsAvi Kapoor

    This Synopsys Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Thursday

  • News

    Absci's Earnings: A Preview

  • NewsRounak Jain

    Cathie Wood's Ark Invest Loads Up On Absci, Offloads CRISPR Therapeutics

  • NewsAvi Kapoor

    Gold Falls Over 1%; Phillips 66 Posts Upbeat Earnings

  • News

    12 Health Care Stocks Moving In Friday's Pre-Market Session

  • News

    Assessing Absci: Insights From 6 Financial Analysts

  • NewsVishaal Sanjay

    Nvidia-Backed Recursion, Ginkgo Bioworks Rally Following FDA's Decision To End Animal Testing

  • NewsAvi Kapoor

    Fastenal Posts Better-Than-Expected Sales, Joins Simulations Plus, Certara And Other Big Stocks Moving Higher On Friday

  • News

    Absci Stock: A Deep Dive Into Analyst Perspectives (7 Ratings)

  • News

    A Glimpse Into The Expert Outlook On Absci Through 7 Analysts

  • News

    12 Health Care Stocks Moving In Tuesday's After-Market Session

  • Press releasePRNewswire

    FDA Approval Race: AI-Powered Innovations Reshape the Healthcare Landscape

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.